Stearoyl-CoA desaturase 1 (SCD1) is a key lipogenic enzyme responsible for endogenous synthesis of monounsaturated fatty acids (MUFA) and plays a key role in various pathophysiology, including fatty liver diseases. In this experimental study the impact of vitamin A deficiency was assessed on SCD1 regulation in relation to kidney biology, under high fructose (HFr) diet-fed condition in rats.
the microsomal enzyme converts the saturated fatty acids (SFA) into MUFA by incorporating 'cis' double bond at 9 th position and thus known as delta-9 desaturase. Palmitic (C16:0) and stearic (C18:0) acids are the preferred substrates for SCD1 and it converts them into palmitoleic (C16:1) and oleic (C18:1) acids, respectively 7 .
The ratio of SFA to MUFA plays a critical role in cell membrane fluidity and function. Studies have demonstrated the key regulatory role of SCD1 in hepatic function and steatosis in HFr-induced experimental models 8 . In addition to well-established link between intake of HFr corn sugar-containing beverages and hepatic steatosis, epidemiological studies have found an association with renal diseases including increased blood pressure, hypertension and albuminuria in humans [9] [10] [11] [12] . However, the impact of vitamin A deficiency on the regulation of SCD1 in the kidney under HFr condition has not been reported. Therefore, the present study was aimed at assessing the effect of chronic feeding of vitamin A-deficient (VAD) diet on kidney biology with special reference to SCD1 regulation in the HFr diet-fed rat model.
Material & Methods
Triglycerides, uric acid and creatinine assay kits were procured from BioSystems S.A. (Barcelona, Spain). Primary antibodies against cyclooxygenase 2 (COX2), inducible nitric oxide synthase (iNOS) and SCD1 were obtained from Santa Cruz Biotechnology, Dallas, TX, USA. Polyvinylidene fluoride membrane and enhanced chemiluminescent reagent used were from Pall Corporation (Portsmouth, UK) and Bio-Rad (Hercules, CA, USA), respectively. For quantitative real-time polymerase chain reaction analysis (qPCR), first strand cDNA synthesis kit (New England Biolabs, Ipswich, MA, USA) and VeriQuest Fast SYBR Green qPCR master mix (Affymetrix, Santa Clara, CA, USA) were used. Primary antibody for glyceraldehyde 3-phosphate dehydrogenase (GAPDH), fatty acid standards, retinol standards, secondary antibodies and Trizol reagents were from Sigma-Aldrich (St. Louis, MO, USA). Immunoprecipitation kit was of GE Healthcare Life Sciences (Marlborough, MA, USA). All the experimental diets were procured from Research Diets, Inc. New Brunswick, NJ, USA.
Experimental design: Forty male weanling (21 day old) Wistar rats were obtained from the National Centre for Laboratory Animal Sciences (now National Animal Resource Facility for Biomedical Research, NARFBR), National Institute of Nutrition, Hyderabad, India. They were broadly divided into four groups, provided isocaloric diets of AIN93G composition for eight weeks initially and designated as control, VAD, HFr and VAD with HFr (VADHFr), consisting of eight rats in each group, except VAD group, which had 16 rats. At the end of eight weeks, blood was drawn from overnight-fasted animals from retro-orbital sinus for plasma biochemical analyses; then, half of the VAD diet-fed rats were shifted to HFr diet (VAD(s)HFr) and the experiment was continued for another eight weeks with the same dietary regimen. The diet and fatty acid composition of oil used in the study were given in the Tables I and II, respectively. Animals were housed individually with an ambient temperature 22±1°C, relative humidity of 50-60 per cent, 12 h:12 h light-dark cycle. The study was approved by the Institutional Animal Ethics Committee of the National Institute of Nutrition (P07/IAEC/NIN/2012/04/SMJ/RATS WNIN M40). Weekly body weights and food intake were recorded. At the end of 16 th wk, blood was collected from retroorbital sinus, after overnight fasting and rats were sacrificed, various tissues were excised, weighed, rapidly frozen in liquid nitrogen and stored at −80°C, until further analysis.
Biochemical analyses: Plasma uric acid and creatinine levels were measured according to the manufacturer's instruction. Retinol levels in the kidney were quantified by HPLC method as described earlier 6 . Kidney thiobarbituric acid reactive substances (TBARS); malondialdehyde (MDA) levels were measured according to the method of Mihara and Uchiyama 13 . Kidney triglyceride content, fatty acid composition and fatty acid desaturase activity indices [ratios of palmitoleic (C16:1) to palmitic (C16:0) acid and oleic (C18:1) to stearic (C18:0) acid], the indicators of SCD1 activity, were calculated as reported earlier 6, 14 .
Kidney histology and immunohistological examination:
Histological staining using haematoxylin and eosin (H and E) and immunohistological staining for SCD1 of the kidney were performed and analyzed as described earlier 6 .
Immunoprecipitation and immunoblotting: Kidney samples (100 mg) were homogenized in T-PER tissue protein extraction reagent (Thermo Scientific, Rockford, USA) supplemented with five per cent protease inhibitor and one per cent phosphatase inhibitor cocktails. After differential centrifugation, a constant amount of protein (10 µg) from the post-mitochondrial fraction was used for immunoprecipitation using SCD1 antibodies, according to the manufacturer's protocol and performed immunoblotting; crude homogenate of 40 µg protein was used to detect the COX2 and iNOS. Expression of GAPDH was used as a loading control and the blots were analyzed using Image J 1.46r software (National Institutes of Health, NY, USA) as reported earlier 6 .
Gene expression by quantitative real-time polymerase chain reaction (qPCR): Total RNA (1 µg) from the kidney was used for cDNA synthesis and Inc., CA, USA), using gene-specific primers (Integrated DNA Technologies Inc., Iowa, USA) for SCD1 (forward: 5'-AACGAGAGGGTTGGTTGT TG-3', reverse: 5'-CCCATGCCTCTGGTCTTTTA-3'). Endogenous expression of β-actin was carried out, using the following forward and reverse primers, respectively; 5'-CTTGCAGCTCCTCCGTCGCC-3' and 5'-ACCCTGGTGCCTAGGGCGG-3', for normalization and relative expression levels were calculated as reported earlier 6 . The primers were synthesised from Integrated DNA Technologies, Inc., Iowa, USA. 
Results
Impact of VAD on body weight, kidney biochemistry and histology: The chronic feeding of VAD diet (either alone or with HFr), displayed lower body weight and weight gain, when compared to the control and HFr-diet fed groups (Table III) . However, the food intake was comparable among all the groups, except, VADHFr group, which had lower food intake 6 . Further, the feeding of VAD diet did not affect the kidney weight, however, found higher, when adjusted for 100 g body weight, compared to the control and HFr groups (Table III) . Further, the feeding of diet that sans vitamin A [either alone (VAD) or with HFr (VADHFr)] significantly reduced the kidney retinol levels (P<0.05) and got elevated (P<0.05), when the animals were shifted from VAD to HFr diet (VAD(s)HFr), however, triglyceride contents of the kidney remained unaltered ( Fig. 1A and B ). In addition, no significant changes were observed with respect to uric acid levels both at 8 th and 16 th wk, particularly in the VAD diet-fed groups. The levels were significantly higher in the HFr diet-fed group, compared to the group that was shifted from VAD to HFr at 8 th wk (Fig. 1C ). The creatinine levels in plasma were comparable among all the groups (Fig. 1D ).
Histological examination of the kidney sections stained with H and E, revealed the normal morphological appearances without any degenerated tubules and focal fat deposits across the groups ( Fig. 2A) .
Impact of VAD on kidney SCD1 expression and fatty acid composition:
Immunohistological examination of the kidney SCD1, revealed that the staining was predominantly found in the distal convoluted tubules and comparable among groups, while the regions of proximal convoluted tubules and glomeruli stained negative for the SCD1 (Fig. 2B) . Further, to confirm the expression status, kidney SCD1 at gene and protein levels were measured and found that neither vitamin A deficiency nor HFr diet had an effect on the expression levels of SCD1 ( Fig. 2C and D) .
Despite unaltered SCD1 expression levels, VAD diet-fed groups, displayed significant increase in oleic (C18:1) acid, with a concomitant reduction of stearic (C18:0) acid levels, as compared to that of HFr diet-fed group. Among PUFA, linoleic (C18:2, n-6), α-linolenic (C18:3, n-3) and dihomo-γ-linolenic (C20:3, n-6) acids showed an increase, while arachidonic (C20:4, n-6) and docosahexaenoic (C22:6, n-3) acids levels decreased in VAD diet-fed groups (VAD and VADHFr), compared to the group consuming HFr diet (Table IV) . In terms of total fatty acids of various classes in the kidney, MUFA levels markedly elevated, while n-6 PUFA levels showed a reduction in response to VAD diet feeding (VAD and VADHFr) as compared with the groups that received HFr diet. However, the SFA and n-3 PUFA levels remained unaltered (Fig. 3A) . Photomicrographs were taken at ×20 using Nikon-Eclipse E800 microscope. Different diets as given in Fig. 1 legend. A B
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The calculated fatty acid desaturase activity index for palmitoleic to palmitic (C16:1/C16:0) was comparable among groups. However, the fatty acid desaturase index for oleic to stearic (C18:1/C18:0) acids was found significantly high in the VAD diet fed groups, when compared with HFr diet-fed group (Fig. 3B ). Impact of VAD on oxidative stress and inflammatory markers: One of the oxidative stress markers, MDA levels were found comparable among the groups (Fig. 3C) . Although, the histological examination showed absence of inflammation, expression of proteins associated with inflammatory process, namely COX2 and iNOS were measured in the kidney. It was observed that the chronic VAD diet feeding (alone and with HFr), had no effect on the COX2, but significantly reduced the expression levels of iNOS, when compared to that of HFr diet. Notably, the COX2 protein levels markedly increased in the group that was shifted to HFr (VAD(s)HFr), as compared to that of VAD diet-fed group (Fig. 3D ).
Discussion
The impact of VAD diet on kidney biology, specifically on lipid metabolism in relation to SCD1 regulation was studied in the present study. As reported earlier, though plasma and liver triglyceride levels were decreased by VAD diet feeding 6 ; in the present study, VAD diet displayed no effect on either kidney triglyceride content or the expression status of SCD1, both at mRNA and protein levels. The MUFA:oleic (C18:1) acid levels markedly increased in VAD diet-fed group. Previously we reported that the feeding of VAD diet attenuated HFr-induced hypertriglyceridemia, hepatic triglyceride accumulation, which was partly through downregulation of liver SCD1 and the observed reduction in liver MUFA level was corroborated with decreased hepatic SCD1 levels 6 . Contrarily, in the kidney, despite no change in the expression levels of SCD1, the oleic acid (C18:1) levels increased in the VAD diet fed groups. In general, oleic acid (C18:1) is obtained either directly through the dietary fat source or by SCD1-mediated conversion of stearic acid (C18:0). As the dietary fat source was common for all the experimental diets, it implicated that the increased activity of SCD1, as reflected by increased fatty acid desaturase index for oleic to stearic acid (C18:1/C18;0), might be attributed for increased oleic acid (C18:1) levels. Although the specific activity of SCD1 was not measured in the present study, earlier studies from our laboratory demonstrated the positive correlation between MUFA and fatty acid desaturase activity indices, an indirect measure of SCD1 activity 6, 14 .
Rezamand et al 15 have reported the MUFA levels in various bovine tissues and its association with the mRNA and protein levels of SCD1. Although, they found a positive correlation between SCD1 expression and desaturases index of oleic to stearic (C18:1/C18:0) acid across the tissues, but failed to observe such correlation within some of the tissues studied and, concluded that association between MUFA and the abundance of SCD1 mRNA or protein appeared to be tissue specific. Similarly, our data from kidney suggested that association between SCD1 (mRNA and/or protein expression) and fatty acid desaturase activity index or MUFA levels was tissue specific.
Iwai et al 16 reported that proximal tubular cells treated with MUFA displayed resistance to SFA-mediated apoptosis. In patients with diabetic nephropathy, overexpression of SCD1 has been found in the podocytes of glomeruli. Further, in the podocytes, overexpression of SCD1 was found to inhibit the SFA; palmitic acid-induced apoptosis and endoplasmic reticulum stress, and thus offering protection against free fatty acid-mediated lipotoxicity in diabetic condition 17 . The data suggest that increased MUFA offers protection against lipotoxicity and thus it can be speculated that under VAD condition, kidney biology undergoes adaptive changes to protect against and/or cope up with the metabolic insult.
In human mesangial cells, all trans-retinoic acid treatment has been shown to increase the expression of COX (2 and 1) and prostaglandin E2 (PGE2) and thus inflammation of kidney cells 18 . On the contrary, in rat glomerular mesangial cells, pre-treatment with retinoic acid has been shown to suppress the transforming growth factor-β-stimulated expression of pro-inflammatory molecule, COX2 and its catalyzed products; PGE2 and thromboxane A2 19 . Although, the COX2 levels remained unaltered in the present study, the decreased expression of iNOS, particularly in the VAD diet fed rats along with lowered kidney retinol status indicated reduced pro-inflammatory status prevailing in the kidney. This affirmed the normal kidney function (as indicated by unaltered plasma uric acid and creatinine levels) and the absence of inflammation, as observed in the histological examinations. The present study lacked data on other parameters such as nephron mass, blood pressure and urine volume.
The observed no change in triglyceride levels was in line with the previous report of de Castro et al 20 , wherein HFr diet feeding did not affect the weight and lipid deposition of the kidney in younger rats of Fischer strain, while the authors observed changes at adult age and concluded age-dependant response to HFr diet. Previously, studies have reported increased oxidative stress and lipid peroxidation in liver and aorta of rats consuming VAD diet. However, the levels of MDA; the secondary product of lipid peroxidation was comparable among all the groups 21, 22 . Over all, the data raised the concern that despite the HFr and VAD diet consumption, there were no phenotypic changes seen in the kidney. It requires further studies to understand the role of these nutrients in kidney biology. It could be possible that the duration of the study was limited or shorter to observe the phenotypic changes in the kidney, including injury and function.
In conclusion, the feeding of VAD diet showed a significant reduction in retinol levels, but elevated the kidney total MUFA, mainly due to increased oleic acid (C18:1) levels, possibly through increased SCD1 desaturase activity, as evident from the higher ratio of oleic (C18:1) to stearic (C18:0) acid, without affecting the SCD1 protein levels. Despite an increase in oleic acid (C18:1), the kidney triglyceride levels remained unaltered by VAD diet consumption, in addition to the morphology and functions. Thus, the data suggest that unlike liver, the interaction between vitamin A status and SCD1 in the kidney under HFr diet-fed condition seems to be divergent and therefore, deeper understanding of SCD1 in relation to kidney biology is required for targeting and/or treating the kidney diseases by dietary and pharmacological agents.
